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Abstract Analysis of a European Union funded biotechnology project on plant
genomics and marker assisted selection in Solanaceous crops shows that the organi-
zation of a dialogue between science and society to accompany technological innova-
tions in plant breeding faces practical challenges. Semi-structured interviews with
project participants and a survey among representatives of consumer and other non-
governmental organizations show that the professed commitment to dialogue on science
and biotechnology is rather shallow and has had limited application for all involved.
Ultimately, other priorities tend to prevail because of high workload. The paper rec-
ommends including results from previous debates and input from societal groups in the
research design phase (prior to communication), to use appropriate media to disseminate
information and to make explicit how societal feedback is used in research, in order to
facilitate true dialogue between science and society on biotechnology.
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Introduction
Modern biotechnology, understood as the development and application of molecular
biology knowledge and technologies in plant breeding, is a regular source of
contention. The use of genetic modification has lead to fierce debates in Europe,
resulting in severe restrictions set on experiments with and market introduction of
genetically modified plants (Lassen et al. 2002; Torgersen et al. 2002). These
debates have demonstrated that innovation in plant biotechnology has to address
two ethical questions. The first question is directly related to the technology, and
raises the issue of whether humankind should be allowed direct intervention in
given biological processes. The second question is related to decision making in
innovation processes, and focuses on how society can use and control the potential
of a technology that can significantly have an impact on our socio-economic
environment (Dyson and Harris 1994; Murphy 2007). Scientists and policy makers
are increasingly convinced that technological innovations need to be accompanied
by a dialogue between science and society that is true to the context and content of
the developments (Goven 2006).
Today, genomics research1 is providing us with an avalanche of data and
information that is opening up new horizons for biotechnological innovations in plant
breeding. Marker assisted selection (MAS) is one of these new opportunities, making
it possible to speed up conventional breeding, as quantitative traits can be traced
directly in the genome of the seedlings with the aid of markers (Collard and Mackill
2007). Although MAS is just a detection tool, and is therefore fundamentally
different from genetic modification, there are three reasons why this technology
could be easily associated, if not confused, with genetic modification, which is a
contested technology. First, genetic modification is also used during research to
establish promising pathways, to test hypotheses on quantitative traits and to develop
suitable markers. Second, the very same plant genomics knowledge that MAS is
based on can be used to develop new applications of genetic modification. Finally,
MAS is one of a range of relatively novel molecular tools that link genomics
knowledge and biotechnological innovation, causing the classic dichotomy between
genetic modification and other techniques to become increasingly vague. With
innovations in biotechnology it has, for example, become possible that genetic
modification is used as one step in the creation of plants or fruits that themselves no
longer contain any genetically modified material. This poses the question of whether
the public still has the opportunity to make a free and informed choice when it
concerns food products made with these technologies (Lammerts van Bueren et al.
2007). So, it is reasonable to expect that public concerns raised in the past might be
raised again. For this reason a proper science-society dialogue seems warranted.
1 Genomics is the study of the entire genome of organisms. It encompasses the determination of the DNA
sequence and related biological functions. DNA sequencing technologies, which are evolving rapidly in
terms of speed and costs, and identification of DNA sequences and expression products (proteins) with the
help of micro arrays and bioinformatics are important tools. Genomics also includes the large scale study
of proteins in a cell type or tissue (proteomics) and the systematic study of the unique chemical
fingerprints that specific cellular processes leave behind, specifically the study of their small molecule
metabolite profiles (metabolomics).
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One of the major lessons from the public debates about genetic modification in
Europe has been that communication is pivotal for the public acceptance of
biotechnology (Schenkelaars and De Vriend 2008). Another lesson has been that
this communication should not have the character of a one-way flow of information
from biotechnologists and food scientists (and producers and regulators) towards
hitherto ignorant consumers. Such a one-way communication strategy is based on
the deficit model. This model explains public resistance to biotechnology as an
effect of lacking knowledge, and thus assumes that information in itself would
create public acceptance of these innovations. Since this strategy has proven to be
ineffective, a shift towards dialogical strategies was observed in the mid 1990s
(Biotechnology and the European Public Concerted Action Group 1998). The rather
generally accepted opinion is that biotechnology needs to be accompanied by a
dialogue2 between public, politics, and science to shape the goals of innovation.
At the core of this need for dialogue is the idea that the public must be involved in
discussions and decisions to ensure societal acceptance on what biotechnology
innovations should proceed and under which conditions they could be implemented
(Klu¨ver et al. 2000; Tait 2001; Jasanoff 2003; Wilsdon and Willis 2004). The ideal
dialogue between science and society is proactive and enables scientists to engage
in a discussion with the public prior to the development of biotechnology
applications (Frewer et al. 2004; Beekman et al. 2008).
The pursuit of a dialogue between science and society with respect to
biotechnology has also been picked up by European research and funding policies
for biotechnology (European Commission 2002).3 However, a case study of a
European project about plant genomics research and marker assisted selection in
2 Literally, a conversation between two or more people (from the Greek dia and logos). Also
‘‘engagement in an exchange of ideas and opinions’’ or ‘‘a discussion between representatives of parties to
a conflict that is aimed at resolution’’ (Merriam-Webster). In other words, interchange and discussion of
ideas or views. This is different from traditional education or dissemination of information, sending
messages, which is unidirectional. An effective dialogue is a mutual learning process, exchanging and
adjusting arguments.
3 The Commission states that ‘‘societal scrutiny and dialogue should accompany and guide the
development of biotechnology and biotechnology’’ (p. 19) and continues that biotechnology has ‘‘given
rise to significant public attention and debate. The Commission welcomes this public debate as a sign of
civic responsibility and involvement. Biotechnology should continue to be accompanied and guided by
societal dialogue. Dialogue in our democratic societies should be inclusive, comprehensive, well
informed and structured. Constructive dialogue requires mutual respect between participants, innovative
approaches, and time. It should be structured in agreement with stakeholders to allow progress, for
example in the provision of better information and mutual understanding. Experience also shows how
important it is that dialogue takes place at the local and national levels, as well as internationally, and the
Commission invites Member States and local actors to take relevant initiatives. Dialogue should be open
for all stakeholders. Public authorities should help to ensure participation by stakeholders with limited
resources. Economic operators, industry and users, who have economic interests at stake, as well as the
scientific community bear a particular responsibility for active participation. The Commission invites
these parties to respond to public concerns, for example through transparency of their visions, policies
and ethical standards. Relevant public information is essential for meaningful dialogue. Providing it
requires focused and proactive efforts. It is especially important that the information needs formulated by
the broad public are taken seriously and responded to. We shall also strive for a balanced and rational
approach, distinguishing between real issues, on which we must act, and false claims’’ (ibid.).
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tomato and potato breeding (EU-SOL) shows that the organization of such a science
and society dialogue faces several practical challenges.
EU-SOL—Characteristics and Communication
EU-SOL (European Union Solanaceae) is a large research project funded by the Sixth
Framework Programme of the European Union. It engages a network of life scientists
from a variety of institutions in Europe plus Argentina, Israel and South Africa. The
emphasis of EU-SOL is on screening and mapping diversity within the plant family
Solanaceae. The biodiversity of Solanaceae is enormous and still underexploited.
This diversity is used in the project to enrich the genetic basis of cultivated plants.
Therefore, a core collection of about 7,000 tomato lines, including some wild relatives,
has been created. All these tomato plants, and a number of potato lines, are screened at
phenotypic and genotypic levels. Furthermore, the project aims at providing genetic
knowledge necessary for the development of high quality solanaceaous crops,
primarily focusing on tomato, secondly on potato, and finally on pepper and eggplant.
The improved quality will be seen in the development of plants containing new traits
that are of benefit to consumers, processors, and producers.
The vast majority of interesting traits in plants are not controlled by a single gene
but by a number of genes plus environmental conditions. Sets of genes responsible
for a certain characteristic are named quantitative trait loci (QTL).4 Unique
recognizable sequences of DNA, typically associated with QTL can be identified
and are called molecular markers. Marker assisted selection (MAS) is based on the
use of these molecular markers, which allows the identification of QTL in plants.
MAS improves the speed and possibilities of classical breeding, since transferring
and combining genes can now happen at a rate and with a precision not previously
possible. The focus of the project is thus on developing molecular tools such as
MAS, which can lead to genetically improved varieties without using the
controversial genetic modification techniques and with plant material that exclu-
sively originates from the Solanaceae family. This does not mean that genetic
modification is not used in the project. To effectively identify QTL and to develop
appropriate markers, genetic modification is still used as a research tool.
(www.eu-sol.wur.nl/about_eu-sol.php).
Although EU-SOL has as its main aim the development of high quality crops,
EU-SOL, in line with EU strategy, also contains work packages including
communication activities that are an integrated part of the project. Since improvement
of consumer-traits, such as organoleptic quality (taste, odor, consistency) and health
4 Quantitative trait loci (QTL) are stretches of DNA that are closely linked to the genes that underlie the
continuous traits (traits that vary continuously and could have any value within a range such as height).
They are often found on different chromosomes. Knowing the number of QTLs that explains variation in
the phenotype trait tells us about the genetic architecture of a trait. It may tell us that a specific trait is
controlled by many genes of small effect or by a few genes of large effect. QTLs can be used to identify
candidate genes underlying a trait. Once a region of DNA is identified as contributing to a phenotype, it
can be sequenced. The DNA sequence of any genes in this region can then be compared to a database of
DNA for genes whose function is already known.
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related traits, are important objectives of the project, one part is specifically aiming at
consumers.5 Other stakeholders, such as NGOs and organizations of growers are also
focus points for dissemination of information. Consumer organizations are thought to
be important links between research on biotechnology and consumers. Information
about food and biotechnology provided by these organizations is usually well trusted
by the public (Gaskell et al. 2006). Finally, these organizations are assumed to have
the ability to link biotechnology to consumer products and to bridge the gap between
science and society. Besides informing these target groups about the goals and
methods of EU-SOL, a dialogue was planned in which consumer organizations have
the possibility to discuss the aims and methods of EU-SOL and provide feedback
(www.eu-sol.wur.nl/about_eu-sol.php).
Methodology
To create a basis for dialogue between the partners in EU-SOL and target groups,
including consumer and non-governmental organizations, opportunities, and
bottlenecks for prospective EU-SOL communication activities had to be identified.
What would be the similarities and differences between the views, opinions, and
values of the project partners and those of the target groups when addressing the
aims, methods, and communication strategies of EU-SOL?
Twenty EU-SOL project partners, representing a variety of countries and
institutes involved, were interviewed in a semi-structured way. Attention was given
to the ideas partners have about the aim and usefulness of dialogue, the framing of
genomics, and the wish for feedback from consumers, consumer organizations, and
other stakeholders. The aim of these interviews was to get a qualitative picture of
the content and variety of views and opinions about the necessity for a societal
dialogue about the EU-SOL project.
The results of these interviews were used as input for a second qualitative survey
among consumer organizations and other target groups throughout Europe about their
own organization, aims of EU-SOL, communication, and genomics. It was decided to
approach all 41 consumer organizations that are members of the Bureau Europe´en des
Unions de Consommateurs (BEUC). BEUC is the European association of consumer
organizations and one of the main consumer lobbying organizations in Brussels.
Results: Interviews with Project Partners
Communication Process
A first result from the 20 interviews with partners in EU-SOL was that,
notwithstanding the whole public debate about genetic modification, about half of
5 Input from European consumer organizations on societal issues related to this project is an important
aspect as well as frequent provision of information to NGOs and the public about the progress of the
project and to the project related developments in science and society. Societal aspects such as GMO
versus genomics and conventional versus organic approaches will be addressed by public participation,
awareness, and outreach (www.eu-sol.wur.nl/about_eu-sol.php).
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the interviewees had not given communication with the broader public much
thought before the interview. Furthermore, most partners had only occasional
contact with stakeholders. Nevertheless, almost all respondents expressed a wish to
develop a good and active dialogue with society and thought the public should be
better informed about and more aware of the possibilities of marker assisted
selection in plant breeding.
Topics that were mentioned to communicate about in a science–society dialogue
included facts and myths about biotechnology, (biotechnological) research and
development, and the possibilities and limitations of genomics. The aim of this
communication would be to raise understanding and reassure confidence among the
public at large. It was thought that more public awareness of problems and
challenges in agriculture and food production could lead to a better understanding of
the goals of biotechnology.
A small number of respondents expressed a certain cynicism that providing
information about EU-SOL would be misused or misinterpreted to serve partisan
positions. Bad experiences during the previous public debates on genetic
modification were given as reason for this cynicism. Some partners felt that
stakeholders, including governments and NGOs, should take responsibility in
supporting new technologies in the field of life sciences.
Some partners also expressed skepticism about the requirement for dialogue
within EU-SOL as a research project. They thought that this was not the right
moment to engage target groups, since the design stage of the project has passed
already and results will only come after many years. Furthermore, this emphasis on
communication was seen to serve political interests and as an artefact of funding
rules and regulations.
Various partners recognized that science–society dialogue has not been optimal
within the context of EU-SOL. Several ideas were voiced to improve this dialogue
between science and society: information should be positive, scientists should be
more transparent, and scientists should alter their detached attitude and sometimes
arrogant approach. On a more practical note, it is suggested that a wider use of
publications in more accessible and popular papers and magazines and direct
communication could help to bridge the gap between scientists and consumers.
Although receiving societal feedback was uncommon for most partners, it has to be
acknowledged that respondents were open to receive and use feedback from other
stakeholders. They were convinced that feedback would ultimately result in better
technological applications and thus to better services for society.
Communication Contents
The EU-SOL partners by-and-large argued that it is important to explain
biotechnology and the subtleties of MAS and genomics in comprehensible language
to the general public and stakeholder organizations, because MAS and genomics are
perceived to remain as difficult and value-laden as biotechnology, specifically
genetic modification, itself. When describing the difference between MAS,
genomics, and genetic modification, the respondents seemed to make a clear
distinction between their own point of view and what they expected the views of
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consumers and consumer organizations to be. When prompted about this distinction,
the answers of the interviewees suggested a divergence among EU-SOL partners.
A small majority of respondents suggested that there is probably little difference
between their own and consumer views: whatever the application, it is all a form of
biotechnology that includes active intervention in the design of plants or species.
Others strongly disagreed with this majority position. According to them, MAS is
not an active intervention in the design of the plant, while genetic modification is.
Unfortunately, in the project partners’ anticipation, consumers seem to conflate
MAS and genetic modification. A third position was to take a more constructive
stance on the important and meaningful distinction between MAS and genetic
modification. These respondents thought that it should be possible to convince the
public that exploiting genomics knowledge through MAS is more acceptable than
genetic modification, as the results are achieved through conventional breeding and
not through direct manipulation in the genetic make-up of the plants. Finally, some
respondents, above all, emphasized the need for increased education of the public to
raise understanding and appreciation of the difference between MAS and genetic
modification.
All partners agreed with the choice to focus on MAS in EU-SOL and did not
expect that MAS will cause much of a public debate. The respondents differed most
in their views about the amount and contents of information to be disseminated by
EU-SOL. Almost all respondents thought that their colleagues would agree with
their views, while during the interviews quite divergent opinions were raised.
Results: Survey of Consumer and Non-governmental Organizations
Communication Process
All 41 member organizations of BEUC were approached several times, however
only fourteen consumer organizations responded to the questionnaire. Forty other
target groups, including environmental organizations, growers, and consultancies,
were approached but only seven of these organizations were eventually willing to
respond to the survey. These seven respondents were three tomato growers, two
farmers’ organizations, one commercial cooperative, and one environmental
organization.
In general, the impression gained is that the majority of the consumer and non-
governmental organizations are not very open to new information or topics
introduced by a research project like EU-SOL. Several organizations indicated to be
interested in new developments around genetic modification but not in MAS or the
use of genomics in plant breeding. Furthermore, it was hard to get in touch with the
right person or representative, and the respondents usually indicated that they had
little time to answer the questions. Reasons given by consumer organizations that
did not answer the questionnaire were lack of expertise, lack of time, no direct
benefit for consumers, standard rules to only answer questionnaires from other
consumer organizations, and to only participate in questionnaires for projects in the
design stage.
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The participating organizations valued dialogue with scientists working on
biotechnology in agriculture and food production. Furthermore, the desire to
influence research priorities through such a dialogue was high. However,
organizations were by-and-large not satisfied with their experiences with such
dialogue and they argued that the exchange of information between science and
society needs to be improved.
Many problems as well as solutions were given with respect to science–society
dialogue about biotechnology. It was commented that it is not easy to stay
up-to-date with scientific developments through reading scientific literature.
Furthermore, there is an overwhelming amount of information, which is very often
not clearly presented. Free Internet newsletters were thought to be a good
information outlet. Another comment was that the initial stage in any dialogue is
difficult, since trust between the parties to the dialogue is pivotal. One view
expressed is that scientists are very often perceived to be paid by the industry, which
creates the impression that they are not neutral.
Communication Contents
The consumer organizations that responded to the questionnaire clearly had
divergent opinions about the usefulness of the uncovering of the genome of fruits
and vegetables, while most other target groups had a more positive attitude. The
consumer organizations had different levels of expertise with respect to develop-
ments in plant breeding. The majority of the respondents (14 out of 21) said that
they do not have sufficient knowledge and there seemed to be some confusion about
different applications of biotechnology. Most respondents (16 out of 21) neverthe-
less thought that there is an important difference between marker assisted selection
and genetic modification and that this difference would also be important for
consumers.
Support for the use of genomics information depended on the type of technology
that it would be applied for. While the use of genomics information for MAS was
supported by a small majority (10 out of 216) of the target groups, the use for
genetic modification still received very low support (5 out of 21). Asked about
different objectives, almost all respondents (16 out of 21) supported the use of
genomics knowledge for conservation of biodiversity, optimization of cultivation
methods, and speeding up of classical breeding. The respondents were also asked
about what they thought that knowledge of uncovering the genome was most likely
to be applied to. MAS and genetic modification were mentioned by almost all
respondents. Optimizing cultivation methods and speeding up of classical breeding
were expected by a small majority of the respondents. Only a minority thought that
it would be used for the conservation of biodiversity. A remarkable feature was the
difference between the expectations of participants between what they thought
genomics information should be used for and what they expected it would be used
for. While only 5 respondents thought it should be used for genetic modification, 14
respondents thought that eventually it would be used for genetic modification.
6 Ten interviewees supported this, 5 had no opinion, 6 were against.
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Comparative Analysis
Communication Process
Discussions among project partners and consumer organizations are very limited.
They seem to restrict discussion to their own communities (i.e., they do not talk to each
other). Only a few project partners had direct contact with target groups and primarily
discussed scientific topics among themselves. Likewise, consumer organizations
preferred communication with other consumer organizations. Despite this low level of
interaction, both project partners and target groups thought that dialogue between the
two groups is important. A majority of the target groups would like to influence
research priorities and project partners would welcome such feedback.
Target groups thought that communication with scientists and access to results of
research in the domain of biotechnology for agriculture and food production is
insufficient. Several project partners stressed the necessity to improve the image of
science, scientists, and biotechnology but some others were skeptical about
communication. Project partners’ experiences in the earlier debates about genetic
modification had been negative. According to the project partners, several NGOs
developed an unbalanced, negative attitude towards genetic modification, which
was based on a limited picture of the pros and cons. They worried that something
similar might happen in the case of EU-SOL.
Project partners and target groups made several suggestions to improve science–
society dialogue. A broader use of scientific papers/publications was suggested by both
groups. Other suggestions made by target groups—e.g., free Internet newsletters, better
collaboration between media and scientists and a trustworthy intermediary to facilitate
dialogue—could also be considered. Several partners suggested direct communication
with the public through schools and universities. They argued that the public should be
encouraged to become more aware of the importance of biotechnology in daily life.
Some project partners thought that information should focus on benefits but target
groups largely disagreed with this idea, since they wanted to be informed about the
whole picture and not just about the benefits of biotechnology. Project partners also
suggested giving attention to facts and myths about biotechnology, technological
development in general, and the possibilities and limitations of genomics.
Hence, although both project partners and consumer organizations in this study
highly valued science–society dialogue, interaction is not yet optimal and hardly
any steps for specific prospective actions have been taken. The most important
reason for this lack of initiative seems to be that contact between parties is rather
limited as a result of structural factors like high workload, low sense of urgency, and
the institutional output assessment of scientists and policy officers (papers, lectures,
lobby results, media attention). BEUC emphasized the importance of two-way
communication but provided no specific ideas on how this could work.
Communication Contents
Several project partners emphasized that EU-SOL does not include the development
of genetically modified organisms (GMOs). Many partners thought that the public
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would have difficulty understanding the difference between MAS and genetic
modification. In contrast, they believed that target groups would understand and
appreciate the difference between the two technologies. Project partners believed
that the acceptance of MAS would not be an issue. Different levels of expertise
existed among target groups and there seemed to be some confusion about the
various biotechnologies. Nevertheless, both groups thought that there is a difference
between MAS and genetic modification. They also thought that this difference
would be important for consumers. However, a large number of consumer
organizations thought that the knowledge of the genome should not be applied to
MAS and this opinion was not based upon lack of knowledge or a conflation
between MAS and genetic modification. A possible explanation is that most target
groups believed that the uncovering of the genome would be used primarily for
genetic modification. Several consumer organizations were therefore skeptical about
the aims of EU-SOL. This sometimes caused resistance to MAS and even towards
the uncovering of the genome.
Conclusions and Recommendations
EU-SOL is not unique in including communication activities, through work
packages, as an integrated part of the project, usually run by a group of social
scientists, to focus on communication and interaction with society. The study of EU-
SOL shows that this is not good enough as an attempt to facilitate science–society
dialogue about biotechnology.
From the interviews it appears that scientists themselves are insufficiently aware
of the different views within their own community about the purpose of this
dialogue. It is important that these differences are made explicit within the project
and that there is consensus building about which perspectives could be used and
presented in dialogue with society at large. The stakeholder questionnaire shows
that the respondents value science–society dialogue, argued that improvements to
this dialogue were necessary, and emphasize the need to influence research
priorities. However, it also showed that a majority of the responding organizations
did not seem to be willing to invest in improving this dialogue for a project that has
been established already.
So, why does it seem to be so difficult to initiate a dialogue starting from
different perspectives and before the targets have been set? It is not for a lack of
guidelines and theory on setting up a proper science-society dialogue. If anything,
the problem would rather be to pick the right tools from a whole plethora
of available approaches (see, e.g., Beekman and Brom 2007; De Cock Buning
et al. 2008).
The so-called Collingridge dilemma poses that it is always too early or too late
for a good science–society dialogue (Collingridge 1980).7 A proper response,
7 Collingridge (1980) formulated this dilemma in terms that combined problems of information and
power. The information problem is related to the fact that impacts cannot easily be predicted until the
technology is extensively developed and widely used. At the same time, control or change is difficult
when the technology has become entrenched.
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however, would be to argue that the Collingridge dilemma is false. Once it has been
acknowledged that societal discussions need to accompany the whole life cycle of
biotechnology development, it is never too early or too late for dialogue. Timing
merely determines what could or should be discussed.
The above line of reasoning does not need to start from the implausible
assumption that research and development (R&D) are activities with predictable
outcomes and steps that can be planned well ahead. In reality, R&D usually has the
characteristics of a learning process, with numerous feedback loops, adaptations,
and sometimes surprising results. In that case, dialogue is still worthwhile, provided
that certain conditions are met. Intervening in an ongoing process of R&D is more
difficult than discussing a clear research agenda in the starting phase, which makes
transparency of the process a necessity. It should also be absolutely clear what
opportunities are left to influence the R&D process and how the feedback of the
stakeholders will be dealt with.
A good dialogue would at the least need the following activities to be included in
such research projects:
• Time for discussion among the participating scientists about the goals and
anticipated outcomes of their research before the project is fully defined;
• Time for discussion between participating scientists and consumer and societal
representatives about the goals and anticipated outcomes of the research before
the project is fully defined.
The above suggestion is very practical and can be implemented in the current
design of life science research projects. All it requires is budgets that cover the time
spent by all project participants on discussions about project goals and outcomes
and also for the time spent by consumer and societal representatives on these
discussions.
But is this sufficient to address the ethical issues concerning acceptable
interventions in biological processes and decisions in innovation processes
effectively? Or do we need more structural changes in the relation between science
and society in order to come to meaningful communication activities? The BEUC
stated in one of its policy papers: ‘‘Only an open decision making process that
would involve consumers at the earliest possible stage will enable a degree of
‘harmony’ between science and society. The informing of consumers may not be
seen as a one-way information system since we believe that the dialogue with and
feedback from stakeholders is of crucial importance’’ (BEUC 2000). Academics like
Wilsdon and Willis (2004) see a role in involving the public and other stakeholders
even earlier through advisory panels and consultation exercises during the selection
and framing of research programs and thematic priorities. They are calling upon
science to ‘‘[come to the] recognition that experimentation continues as scientific
and technological knowledge diffuses into complex social systems’’ (p. 61). Goven
(2006) points to the need to ‘‘let the results of previous dialogues and consultations
frame our current ones […] to enable participants to address current policies in
greater detail’’ (p. 111). And finally, Jasanoff (2003) pleads for a change in ‘‘social
contract’’ by questioning the value of peer review as a system of moral scrutiny in
comparison to a much more needed public accountability system. This type of
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structural approaches could strike a better balance between societal needs and
demands and the technological imperative.
Both recommendations, practical and structural, would require a policy change
for the design of biotechnology projects. Goals highlighted in debates about relevant
issues such as food quality and sustainable agriculture must be used as a starting
point for research proposals. Scientific plus societal criteria for evaluation must be
made explicit prior to take off. Societal groups should be actively involved in
establishing these criteria and the assessment of research proposals and the
evaluation during different stages of the implementation of projects. Finally,
research proposals should make explicit how societal feedback will be used in
research and include the use of appropriate media to inform the public. Only when
science–society dialogue is matured, will it be possible to appropriately address the
two ethical questions posed at the start of this paper—permissible intervention in
biological processes and use and control of technologies.
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